Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A multiagent strategy to decrease regimen-related toxicity in children undergoing allogeneic hematopoietic stem cell

Ian Thornley1, Leslie E Lehmann, Lillian Sung

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|August 21, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting.

Frontiers in oncology·2025
Same author

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study.

American journal of hematology·2025
Same author

Changes in Gut Microbial Diversity and Correlation with Clinical Outcome in Children with Acute Myeloid Leukemia Receiving Induction Chemotherapy.

Children (Basel, Switzerland)·2025
Same author

Is rotavirus aetiology in young children with acute diarrhoea associated with sociodemographic and clinical factors, including rotavirus vaccination status? A secondary cross-sectional analysis of the ABCD trial.

BMJ global health·2025
Same author

High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE Study.

Pediatric blood & cancer·2025
Same author

Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.

EJHaem·2025
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

End of headings.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
Same journal

Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
See all related articles
This summary is machine-generated.

This pilot study shows a novel combination regimen reduced toxicity after allogeneic hematopoietic stem cell transplantation (HSCT) in children. The approach is feasible and well-tolerated, suggesting potential for reducing HSCT complications.

Area of Science:

  • Hematology
  • Pediatric Transplantation
  • Clinical Nutrition

Background:

  • Regimen-related toxicity (RRT) is a significant complication following allogeneic hematopoietic stem cell transplantation (HSCT).
  • Reducing RRT is crucial for improving outcomes in pediatric HSCT patients.
  • Novel strategies are needed to mitigate treatment-related toxicities.

Purpose of the Study:

  • To evaluate the feasibility and efficacy of a fixed combination regimen for reducing RRT in children undergoing HSCT.
  • To assess the impact of the novel regimen on specific toxicities and engraftment.

Main Methods:

  • A pilot study involving 37 pediatric HSCT patients treated with ursodeoxycholic acid, folinic acid, vitamin E, and parenteral nutrition.
  • Outcomes were compared to a historical control group (n=131).

Related Experiment Videos

  • Compliance and specific toxicity parameters (mucositis, hepatic toxicity, engraftment time) were assessed.

    • Main Results:

    • High compliance (>=90%) achieved for oral medications in 86% of patients.
    • Significant reduction in mucositis prevalence and severity (P=.008, P=.004).
    • Less severe hepatic toxicity (P=.007) and shorter time to engraftment (P=.02) observed compared to controls.

    Conclusions:

    • The combination regimen is feasible and well-tolerated in the peritransplantation period for pediatric HSCT.
    • The regimen demonstrated potential efficacy in reducing RRT, particularly in high-risk patients.
    • Combination approaches warrant further investigation to decrease HSCT morbidity.